Onyx continues slide, despite positive physician feedback at ASH
14 December 2011
Donna Young
Please Login to read the full article.
14 December 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Onyx carfilzomib NDA accepted by FDA, but review time up in the air
- Onyx delays US filing for carfilzomib multiple myeloma drug, slightly
- Will FDA's nod for Millennium's subQ Velcade be a thorn in Onyx's side?
- Array BioPharma reports positive early data for two haematology drugs
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
